Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/24/2026

Methylprednisolone Should Not Be Used in Acute Cervical Spinal Cord Injury from Hanging

Guideline Recommendation

  • The 2020 French spinal cord injury guidelines issue a GRADE 1 strong recommendation against early administration of methylprednisolone after acute traumatic cervical spinal cord injury to improve neurological prognosis. 1

Lack of Neurological Benefit

  • NAS​CIS 1 trial (dose‑comparison of 1 g vs 100 mg methylprednisolone) showed no difference in motor‑score improvement between the two steroid regimens; no control group was included. GRADE low (single trial, no comparator). 1
  • NAS​CIS 2 trial reported a modest motor‑score gain at 6 months only when steroids were started within 8 hours, but the benefit was not standardized, not replicated in later studies, and considered clinically uncertain. GRADE moderate (single RCT with methodological concerns). 2
  • NAS​CIS 3 trial compared 24‑hour vs 48‑hour steroid infusion and found no additional motor improvement with the longer regimen. GRADE low (single trial, no superiority). 3
  • A large Canadian propensity‑score cohort demonstrated no improvement in one‑year motor function among patients receiving steroids versus those who did not. GRADE moderate (observational data with robust adjustment). 4

Harm Profile of Methylprednisolone

  • Urinary tract infections occurred more frequently in patients treated with methylprednisolone compared with placebo. GRADE moderate (consistent across trials). 5
  • In NAS​CIS 2, the overall infection rate was 7 % in the steroid group versus 3 % in the placebo group; the difference did not reach statistical significance but indicates a trend toward higher infection risk. GRADE low (single trial, non‑significant). 2

Insufficient Evidence for Steroid Use (Other Guidelines)

  • The 2019 Congress of Neurological Surgeons guidelines state that evidence is insufficient to recommend methylprednisolone for acute spinal cord injury and emphasize the need to consider its complication profile. GRADE low (expert consensus). 6

Evidence‑Based Interventions to Prioritize

  • Maintain mean arterial pressure > 70 mmHg for the first 2–3 days after injury using continuous arterial line monitoring to support spinal cord perfusion. GRADE high (strong physiologic rationale and consistent outcome data). 1, 3, 5
  • Immediate transfer to a specialized spinal cord injury center reduces morbidity and long‑term mortality; the recommendation carries a GRADE 2+ (moderate‑to‑strong) rating. 1, 4
  • Early magnetic resonance imaging should be obtained when neurological deficits are not explained by computed tomography, facilitating timely diagnosis and management. GRADE moderate (imaging improves decision‑making). 1, 2
  • Avoid hypotension (systolic blood pressure < 90 mmHg) rigorously for the first 5–7 days post‑injury to prevent secondary spinal cord ischemia. GRADE high (well‑established hemodynamic target). 3, 5

Critical Pitfall

  • Do not delay transfer or other proven interventions while considering methylprednisolone; the drug provides no neurological benefit and increases infection risk, whereas delayed transfer to a specialized center is associated with worsened outcomes. GRADE high (strong evidence from multiple sources). 1, 4